These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
262 related articles for article (PubMed ID: 16163539)
1. A phase I combination chemotherapy study of biweekly paclitaxel and S-1 administration in patients with advanced gastric cancer. Hokita S; Aikou T; Miyazono F; Ishigami S; Aridome K; Maenohara S; Saihara T; Suenaga K; Nomura H; Maeda S; Takatori H; Arima H; Uchikado Y; Natsugoe S; Takao S Cancer Chemother Pharmacol; 2006 Jun; 57(6):736-40. PubMed ID: 16163539 [TBL] [Abstract][Full Text] [Related]
2. Phase I study of S-1 and biweekly docetaxel combination chemotherapy for advanced and recurrent gastric cancer. Takahashi I; Emi Y; Kakeji Y; Tokunaga E; Ushiro S; Oki E; Watanabe M; Baba H; Maehara Y Oncol Rep; 2006 Apr; 15(4):849-54. PubMed ID: 16525670 [TBL] [Abstract][Full Text] [Related]
3. [A phase I study of combination chemotherapy using TS-1 and weekly paclitaxel for advanced gastric cancer]. Fujiwara Y; Fujita J; Kan K; Tsukahara K; Takiguchi S; Miyata H; Yasuda T; Doki Y; Monden M Gan To Kagaku Ryoho; 2006 Jan; 33(1):45-8. PubMed ID: 16410697 [TBL] [Abstract][Full Text] [Related]
4. A phase I study of S-1 administration and a 24-h infusion of cisplatin plus paclitaxel in patients with advanced gastric cancer. Iwase H; Shimada M; Tsuzuki T; Okeya M; Kobayashi K; Hibino Y; Watanabe H; Goto H Anticancer Res; 2006; 26(2B):1605-9. PubMed ID: 16619579 [TBL] [Abstract][Full Text] [Related]
5. Phase I study of a combination of s-1 and weekly paclitaxel in patients with advanced or recurrent gastric cancer. Ueda Y; Yamagishi H; Ichikawa D; Morii J; Koizumi K; Kakihara N; Shimotsuma M; Takenaka A; Yamashita T; Kurioka H; Nishiyama M; Morita S; Nakamura K; Sakamoto J Oncology; 2005; 69(3):261-8. PubMed ID: 16138002 [TBL] [Abstract][Full Text] [Related]
6. A multicenter phase II study of biweekly paclitaxel and S-1 combination chemotherapy for unresectable or recurrent gastric cancer. Nakajo A; Hokita S; Ishigami S; Miyazono F; Etoh T; Hamanoue M; Maenohara S; Iwashita T; Komatsu H; Satoh K; Aridome K; Morita S; Natsugoe S; Takiuchi H; Nakano S; Maehara Y; Sakamoto J; Aikou T; Cancer Chemother Pharmacol; 2008 Nov; 62(6):1103-9. PubMed ID: 18317763 [TBL] [Abstract][Full Text] [Related]
7. Phase I/II trial of combination therapy with S-1 and weekly paclitaxel in patients with unresectable or recurrent gastric cancer. Inada S; Tomidokoro T; Fukunari H; Sato T; Hatano T; Nishimura A; Kawauchi Y; Nikkuni K; Shimizu T; Sato T; Yanagi M; Takahashi S; Yoshida H; Sugita M; Hayashi T Cancer Chemother Pharmacol; 2009 Jan; 63(2):267-73. PubMed ID: 18379784 [TBL] [Abstract][Full Text] [Related]
8. [Combination chemotherapy study of biweekly paclitaxel and S-1 administration in patients with advanced gastric cancer]. Hokita S; Aikou T; Ishigami S; Miyazono F; Nakajo A; Uenosono Y; Hamanoue M; Aridome K; Natsugoe S Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():95-8. PubMed ID: 16897981 [TBL] [Abstract][Full Text] [Related]
9. Phase I/II study of a combination of S-1 and weekly paclitaxel in patients with advanced or recurrent gastric cancer. Kawabata R; Fujiwara Y; Doki Y; Fujita J; Tsukahara Y; Yamasaki M; Miyata H; Takiguchi S; Monden M Oncology; 2007; 72(3-4):219-25. PubMed ID: 18176087 [TBL] [Abstract][Full Text] [Related]
10. Phase I/II study of 3-week combination of S-1 and cisplatin chemotherapy for metastatic or recurrent gastric cancer. Lee JL; Kang HJ; Kang YK; Ryu MH; Chang HM; Kim TW; Sohn HJ; Kim H; Lee JS Cancer Chemother Pharmacol; 2008 Apr; 61(5):837-45. PubMed ID: 17579864 [TBL] [Abstract][Full Text] [Related]
11. A phase I study of bi-weekly combination therapy with S-1 and docetaxel for advanced or recurrent gastric cancer. Rino Y; Takanashi Y; Yukawa N; Saeki H; Wada H; Kanari M; Yamada R; Satoh T; Yamamoto N; Imada T Anticancer Res; 2006; 26(2B):1455-62. PubMed ID: 16619558 [TBL] [Abstract][Full Text] [Related]
12. Phase I pharmacokinetic study of S-1 plus cisplatin in patients with advanced gastric carcinoma. Ajani JA; Faust J; Ikeda K; Yao JC; Anbe H; Carr KL; Houghton M; Urrea P J Clin Oncol; 2005 Oct; 23(28):6957-65. PubMed ID: 16145066 [TBL] [Abstract][Full Text] [Related]
13. Phase II study of S-1 monotherapy in paclitaxel- and cisplatin-refractory gastric cancer. Lee SJ; Cho SH; Yoon JY; Hwang JE; Bae WK; Shim HJ; Chung IJ Cancer Chemother Pharmacol; 2009 Dec; 65(1):159-66. PubMed ID: 19479256 [TBL] [Abstract][Full Text] [Related]
14. Phase I study of combination therapy with S-1 and docetaxel (TXT) for advanced or recurrent gastric cancer. Yoshida K; Hirabayashi N; Takiyama W; Ninomiya M; Takakura N; Sakamoto J; Nishiyama M; Toge T Anticancer Res; 2004; 24(3b):1843-51. PubMed ID: 15274365 [TBL] [Abstract][Full Text] [Related]
15. A multi-center phase II study of S-1 plus paclitaxel as first-line therapy for patients with advanced or recurrent unresectable gastric cancer. Lee JJ; Kim SY; Chung HC; Lee KH; Song HS; Kang WK; Hong YS; Choi IS; Lee YY; Woo IS; Choi JH Cancer Chemother Pharmacol; 2009 May; 63(6):1083-90. PubMed ID: 18813927 [TBL] [Abstract][Full Text] [Related]
16. A phase I study of paclitaxel, cisplatin, and fluorouracil (TCF) for advanced gastric cancer. Hara T; Omura K; Hirano M; Asada Y; Munemoto Y; Sakamoto J Cancer Chemother Pharmacol; 2007 Apr; 59(5):631-6. PubMed ID: 16924496 [TBL] [Abstract][Full Text] [Related]
17. [S-1 combined with weekly paclitaxel in patients with advanced gastric cancer]. Gotoh M; Kawabe S; Takiuchi H Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():91-4. PubMed ID: 16897980 [TBL] [Abstract][Full Text] [Related]
18. Phase I evaluation of continuous 5-fluorouracil infusion followed by weekly paclitaxel in patients with advanced or recurrent gastric cancer. Kondo K; Kobayashi M; Kojima H; Hirabayashi N; Kataoka M; Araki K; Matsui T; Takiyama W; Miyashita Y; Nakazato H; Nakao A; Sakamoto J Jpn J Clin Oncol; 2005 Jun; 35(6):332-7. PubMed ID: 15961435 [TBL] [Abstract][Full Text] [Related]
19. A phase I study of triplet combination chemotherapy of paclitaxel, cisplatin and S-1 in patients with advanced gastric cancer. Kimura Y; Yano H; Imamura H; Fujitani K; Imano M; Tokunaga Y; Matsuoka M; Kurokawa Y; Shimokawa T; Takiuchi H; Tsujinaka T; Furukawa H Jpn J Clin Oncol; 2013 Feb; 43(2):125-31. PubMed ID: 23225911 [TBL] [Abstract][Full Text] [Related]
20. A phase II multicentric trial of S-1 combined with 24 h-infusion of cisplatin in patients with advanced gastric cancer. Iwase H; Shimada M; Tsuzuki T; Horiuchi Y; Kumada S; Haruta J; Yamaguchi T; Sugihara M; Ina K; Kusugami K; Goto S Anticancer Res; 2005; 25(2B):1297-301. PubMed ID: 15865081 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]